Metamfepramone

Metamfepramone is a stimulant drug that belongs to the phenethylamine and amphetamine chemical classes. It is known for its use as an anorectic agent, which means it is used to suppress appetite.
Chemical Structure and Properties[edit]
Metamfepramone, also known as dimethylcathinone, has a chemical structure similar to that of cathinone, a naturally occurring stimulant found in the khat plant. The chemical formula for metamfepramone is C11H15NO, and it has a molecular weight of 177.24 g/mol.
Pharmacology[edit]
Metamfepramone acts primarily as a norepinephrine and dopamine reuptake inhibitor, which leads to increased levels of these neurotransmitters in the brain. This action is responsible for its stimulant and appetite-suppressing effects. The drug has a similar mechanism of action to other stimulants like amphetamine and methylphenidate.
Medical Uses[edit]
Metamfepramone has been used in the treatment of obesity due to its appetite-suppressing properties. It has also been used to treat conditions such as narcolepsy and attention deficit hyperactivity disorder (ADHD), although its use in these conditions is less common compared to other stimulants.
Side Effects[edit]
Common side effects of metamfepramone include insomnia, dry mouth, increased heart rate, and elevated blood pressure. Long-term use can lead to dependence and potential cardiovascular issues.
Legal Status[edit]
The legal status of metamfepramone varies by country. In some regions, it is classified as a controlled substance due to its potential for abuse and dependence.
History[edit]
Metamfepramone was first synthesized in the early 20th century and has been used in various medical applications since then. However, its use has declined over the years due to the development of newer and safer medications.
See Also[edit]
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
